Variability of plasma homovanillic acid over 13 months in patients with schizophrenia; relationship with the clinical response and the Wisconsin card sort test

Neurochem Res. 2011 Aug;36(8):1336-43. doi: 10.1007/s11064-011-0448-8. Epub 2011 Apr 8.

Abstract

In the present study we have measured, on a monthly basis, the concentration of plasma homovanillic acid (pHVA) in schizophrenic patients during 13 months of their pharmacological treatment. The average pHVA values of each patient were within the range of 7.30-17.70 ng/ml and the coefficients of variation for each patient (CV %) were within the range of 13-33%. Half of the patients that showed higher pHVA CV% values also showed higher scores on the Brief Psychiatric Rating Scale at the beginning of the study, and improved more after 6 months, when compared to the remaining 50% with lower CV% values. There was no significant relationship between the scores of the Wisconsin Card Sort Test and the concentration or the CV% of the pHVA of each patient. A greater variability in the pHVA may be associated with a greater plasticity of the dopaminergic system and a better clinical response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use*
  • Female
  • Homovanillic Acid / blood*
  • Humans
  • Male
  • Neuropsychological Tests
  • Psychiatric Status Rating Scales*
  • Schizophrenia / blood*
  • Schizophrenia / drug therapy*
  • Schizophrenia / physiopathology*
  • Young Adult

Substances

  • Antipsychotic Agents
  • Homovanillic Acid